These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 486305)

  • 1. Distribution of misonidazole in human tumours and normal tissues.
    Ash DV; Smith MR; Bugden RD
    Br J Cancer; 1979 May; 39(5):503-9. PubMed ID: 486305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in man.
    Bleehen NM; Grant RM; Jones DH; Roberts JT; Workman P; Gleave JR; Hardy DG; Holmes AE
    Br J Radiol; 1983 Nov; 56(671):859-63. PubMed ID: 6626877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of apparent low levels of misonidazole in human tumours.
    Ash DV; Smith MR
    Clin Radiol; 1980 Mar; 31(2):233-7. PubMed ID: 7363558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
    Dische S; Saunders MI; Riley PJ; Hauck J; Bennett MH; Stratford MR; Minchinton AI
    Br J Cancer; 1981 Mar; 43(3):344-9. PubMed ID: 7225285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic, bladder wall, and bladder tumor concentration of misonidazole following intravesical administration in the rat.
    Fathi MA; Fisher GJ; Pageau R; Tahan TW; Nigam VN; Brailovsky CA; Elhilali MM
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1397-400. PubMed ID: 6885552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G; Canal P; Bugat R; Soula G; Combes PF
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
    Garrecht BM; Chapman JD
    Br J Radiol; 1983 Oct; 56(670):745-53. PubMed ID: 6616139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The penetration of misonidazole into spontaneous canine tumours.
    White RA; Workman P; Owen LN; Bleehen NM
    Br J Cancer; 1979 Aug; 40(2):284-94. PubMed ID: 289406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
    Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
    Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations of misonidazole in therapeutics.
    Matheson I; Plowman PN; Johnston A
    Hum Toxicol; 1984 Feb; 3(1):29-36. PubMed ID: 6698564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799.
    Dische S; Saunders MI; Dunphy EP; Bennett MH; Des Rochers C; Stratford MR; Minchinton AI; Orchard RA
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1109-11. PubMed ID: 2943708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The penetration of misonidazole into a mature structural cartilage.
    Langler AJ; Bugden RD; Gibson P
    Br J Cancer; 1982 Feb; 45(2):282-5. PubMed ID: 7059476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dexamethasone in the modification of misonidazole pharmacokinetics.
    Jones DH; Bleehen NM; Workman P; Walton MI
    Br J Cancer; 1983 Oct; 48(4):553-7. PubMed ID: 6626454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of misonidazole enantiomers.
    Williams KM
    Clin Pharmacol Ther; 1984 Dec; 36(6):817-23. PubMed ID: 6499361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
    Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
    Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of misonidazole after intravesical administration in cases of carcinoma of the bilharzial bladder.
    Awwad HK; el-Merzabani MM; Burgers MV
    Br J Cancer Suppl; 1978 Jun; 3():297-8. PubMed ID: 277248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ; Chapman JD
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
    Chin JB; Rauth AM
    Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacokinetics of misonidazole in the dog.
    White RA; Workman P; Freedman LS; Owen LN; Bleehen NM
    Eur J Cancer (1965); 1979 Oct; 15(10):1233-42. PubMed ID: 520395
    [No Abstract]   [Full Text] [Related]  

  • 20. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.